For over a century, pathologists have diagnosed diseases by examining tissue architecture under a microscope. However, modern precision medicine relies on molecular assays—such as DNA sequencing, RNA expression profiling, and epigenetic mapping—to select targeted therapies. While highly accurate, these molecular tests are expensive, time-consuming, and require destroying physical tissue samples.
A major research direction in computational pathology flips this paradigm. It demonstrates that a tumor's molecular state is not entirely hidden; rather, it leaves distinct physical footprints in tissue structure. By leveraging deep learning, researchers can now infer high-dimensional genomic, transcriptomic, and epigenetic signatures directly from standard, low-cost Hematoxylin and Eosin (H&E) stained histopathology images.
The Biological Intuition: Why Phenotype Reflects Genotype
Why should an abstract sequence of nucleotides or a chemical modification on a DNA strand alter the visual pattern of a tissue slide? The answer lies in the cascade from genotype to phenotype.
When a cell undergoes an oncogenic mutation or experiences widespread genomic instability, its internal machinery is rewired. This rewiring alters cellular morphology, nuclear texture, mitotic rates, and metabolic adaptations. Crucially, these changes extend beyond individual cells to the broader tissue microenvironment. For example, hypermutated tumors often trigger a massive immune response, recruiting tumor-infiltrating lymphocytes and altering local cell density.
As noted by Dan‐Yang Yuan et al. in Breast cancer homologous recombination deficiency prediction from pathological images with a sufficient and representative Transformer, complex genomic instability like Homologous Recombination Deficiency (HRD) manifests as detectable morphological fingerprints in tissue structure. Similarly, Amirali Darbandsari et al. demonstrated in AI-based histopathology image analysis reveals a distinct subset of endometrial cancers that automated models can capture visual correlates of high copy-number abnormalities even when standard protein-based assays fail to detect them.
Deep neural networks act as high-dimensional pattern recognizers. They pick up on these sub-visual cellular textures, spatial arrangements, and microenvironmental cues that are too subtle or complex for human pathologists to reliably quantify.
The Computational Mechanism: Mapping Pixels to Omics
The primary technical challenge in this field is one of scale and resolution. A standard whole-slide image (WSI) is a gigapixel file containing billions of pixels, yet the molecular label (e.g., the presence of a mutation or a specific gene expression level) is typically provided as a single global label for the entire tissue sample.
To bridge this gap, researchers rely on Multiple Instance Learning (MIL) and Latent Space Alignment.
Multiple Instance Learning with Heterogeneity Aware Aggregation
In a standard MIL workflow, a WSI is broken down into thousands of small, manageable image patches (instances). A feature extractor (often a convolutional neural network or a vision transformer) converts these patches into low-dimensional vectors. The core magic happens during the aggregation step, where the model must determine which patches contain the visual proxies of the molecular signature.
Instead of simply averaging patch features—which washes out localized signals—or taking the maximum prediction—which ignores the broader tissue context—modern frameworks model the entire distribution of tissue patterns. Heather D. Couture et al. introduced an MIL framework in Multiple Instance Learning for Heterogeneous Images: Training a CNN for Histopathology that uses a quantile function to aggregate local tissue predictions. By capturing the full distribution of tissue heterogeneity, the model successfully infers complex genetic subtypes and receptor statuses from standard images.
Cross-Modal Latent Space Alignment
To predict continuous molecular values, such as bulk RNA-seq expression levels, models are trained to map visual features directly into a molecular embedding space.
[ Whole Slide Image ] ──> [ Patch Extraction ] ──> [ MIL Aggregation ]
│
▼
[ Predicted Molecular Space ] <── [ Alignment Loss ] ──> [ Latent Embedding ]
▲
│
[ Ground Truth Omics ]
For instance, the authors of Learning to predict RNA sequence expressions from whole slide images with applications for search and classification developed a framework that generates latent embeddings serving as digital fingerprints. By training the model to simultaneously classify cancer subtypes and regress gene expression, the system forces its internal representations to align visual tissue patterns with a space correlated with molecular expression.
This alignment allows models to act as a generative proxy for missing data. Junjie Zhou et al. showed in Robust Multimodal Survival Prediction with Conditional Latent Differentiation Variational AutoEncoder that by aligning visual and genomic latent distributions during training, the model can "reconstruct" functional genomic embeddings directly from tissue slides at test time, maintaining high prognostic accuracy even when physical sequencing data is completely missing.
Mapping Across the Central Dogma
This research direction has proven successful at extracting signatures from every level of the central dogma of molecular biology: DNA, RNA, and epigenetic modifications.
1. DNA Mutations and Genomic Alterations
Deep learning models can identify specific oncogenic drivers directly from tissue slides. In Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection, Gabriele Campanella et al. fine-tuned a massive pathology foundation model to predict EGFR mutation status in lung adenocarcinoma, demonstrating that the model could significantly reduce the need for tissue-consuming rapid molecular tests. For brain tumors, Weiwei Wang demonstrated in Neuropathologist-level integrated classification of adult-type diffuse gliomas using deep learning from whole-slide pathological images that deep learning can predict integrated diagnoses—combining histological and molecular features like IDH mutation status—bypassing the need for time-consuming genetic sequencing.
2. RNA Expression and Transcriptomic Subtypes
Beyond binary mutations, models can infer continuous transcriptomic profiles. Daniela Allende et al. in Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study trained a deep learning model to estimate a complex 10-gene expression signature directly from standard liver biopsy slides, successfully identifying patients who would benefit from specific immunotherapies. To handle the spatial variation of these transcripts, Henning Reis in Histomolekulare Klassifikation des Urothelkarzinoms der Harnblase trained models on correlation coefficients rather than discrete labels, capturing intratumoral transcriptomic heterogeneity directly from H&E slides.
3. Epigenetic Methylation States
The visual-molecular link extends even to chemical modifications of DNA that regulate gene expression without altering the genetic code. In A Novel Approach to Linking Histology Images with DNA Methylation, Manahil Raza et al. introduced a graph neural network framework to predict gene group-level DNA methylation states from WSIs, confirming that routine histopathology images contain structural cues reflecting epigenetic alterations.
Phenotypic Convergence
A foundational insight emerging from large-scale pan-cancer studies is the concept of phenotypic convergence: distinct genetic alterations often result in identical structural changes in tissue.
In a massive pan-cancer study, Salim Arslan et al. trained over 12,000 deep learning models in A Systematic Pan-Cancer Study on Deep Learning-Based Prediction of Multi-Omic Biomarkers from Routine Pathology Images. They discovered that certain high-impact genetic mutations create universal visual signals of cellular chaos that remain consistent across multiple entirely different cancer types.
This phenomenon is beautifully exploited in Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology. The authors demonstrated that hypermutated tumors resulting from two completely separate genetic pathways (POLE mutations and microsatellite instability) converge on a shared morphological phenotype. Both pathways produce increased tumor-infiltrating lymphocytes and highly specific growth patterns. Because of this shared visual language, a model can be trained on a common biomarker to successfully detect a much rarer, clinically vital mutation, proving that morphology acts as a reliable, unifying proxy for the underlying biology.